Clovis Oncology, Inc. Quarterly Common Stock, Shares, Issued from Q4 2011 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Clovis Oncology, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2011 to Q3 2022.
  • Clovis Oncology, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2022 was 145M shares, a 13.2% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 145M +16.8M +13.2% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 144M +26.1M +22% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 144M +39.3M +37.6% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 129M +25.4M +24.5% Dec 31, 2021 10-Q 2022-11-09
Q3 2021 128M +39.7M +44.9% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 118M +30.2M +34.3% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 105M +31.1M +42.3% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 104M +48.7M +88.7% Dec 31, 2020 10-K 2022-02-24
Q3 2020 88.3M +33.5M +61.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 88.2M +35M +65.9% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 73.5M +20.5M +38.7% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 55M +2.16M +4.09% Dec 31, 2019 10-K 2021-02-25
Q3 2019 54.8M +2.1M +3.98% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 53.2M +533K +1.01% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 53M +2.3M +4.53% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 52.8M +2.23M +4.42% Dec 31, 2018 10-K 2020-02-26
Q3 2018 52.7M +3.71M +7.56% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 52.6M +3.79M +7.77% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 50.7M +5.93M +13.2% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 50.6M +11.8M +30.6% Dec 31, 2017 10-K 2019-02-28
Q3 2017 49M +10.4M +27% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 48.8M +10.3M +26.9% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 44.8M +6.41M +16.7% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 38.7M +365K +0.95% Dec 31, 2016 10-K 2018-02-27
Q3 2016 38.6M +302K +0.79% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 38.5M +4.35M +12.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 38.4M +4.3M +12.6% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 38.4M +4.38M +12.9% Dec 31, 2015 10-K 2017-02-23
Q3 2015 38.3M +4.32M +12.7% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 34.1M +183K +0.54% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 34.1M +161K +0.48% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 34M +79.9K +0.24% Dec 31, 2014 10-K 2016-02-29
Q3 2014 34M +3.79M +12.6% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 34M +3.79M +12.6% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 33.9M +7.68M +29.3% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 33.9M +7.69M +29.3% Dec 31, 2013 10-K 2015-02-27
Q3 2013 30.2M +4.03M +15.4% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 30.2M +4.03M +15.4% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 26.2M +3.84M +17.2% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 26.2M +3.83M +17.1% Dec 31, 2012 10-K 2014-02-28
Q3 2012 26.1M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 26.1M Jun 30, 2012 10-Q 2012-08-10
Q1 2012 22.4M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 22.4M Dec 31, 2011 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.